Thin-layer chromatographic identification test
201
Test solution
Weigh a portion of Capsules, equivalent to 20 mg of acitretin. Grind to a fine powder, then triturate for 30 seconds with 2 mL of tetrahydrofuran. Transfer the suspension to a 12-mL conical centrifuge tube, and centrifuge to obtain a clear supernatant.
Standard solution
Dissolve an accurately weighed quantity of
USP Acitretin RS in tetrahydrofuran to obtain a solution containing about 10 mg per mL.
Application volume:
10 µL.
Developing solvent system:
a mixture of chloroform and methanol (80:20).
Procedure
Proceed as directed in the chapter, and then air-dry. Spray the plate with a saturated solution of antimony trichloride in chloroform (25 g in 100 mL) followed by concentrated sulfuric acid, and then locate the spots.
Dissolution
711
Medium:
3% sodium lauryl sulfate in deaerated water, pH 9.6 to 10.0; 900 mL.
Apparatus 1:
100 rpm.
Time:
30 minutes.
Determine the amount of acitretin (C21H26O3) dissolved employing the following method.
Standard solution
Transfer about 14 mg of
USP Acitretin RS, accurately weighed, to a 500-mL volumetric flask. Dissolve in 50 mL of alcohol, and dilute with
Medium to volume. For Capsules labeled to contain 10 mg, transfer 20.0 mL of this solution to a 50-mL volumetric flask, and dilute with
Medium to volume.
Capsule shell preparation
Dissolve 6 clean empty-shell Capsules in 900 mL of Medium.
Test solution
Use portions of the solution under test passed through a suitable 0.45-µm filter.
Procedure
Determine the amount of C
21H
26O
3 dissolved by employing UV absorption at the wavelength of maximum absorbance at about 347 nm, using 2-mm cells, in comparison with the appropriate
Standard solution. Use the
Medium as a blank. Determine the absorbance of the
Capsule shell preparation under the same conditions. Calculate the amount of acitretin (C
21H
26O
3) dissolved by the following formula:
in which
AU is the absorbance of the
Test solution; ACS is the Capsule shell correction, calculated as shown below;
CS is the concentration, in mg per mL, of the appropriate
Standard solution; 900 is the volume, in mL, of
Medium; 100 is the conversion factor to percentage;
AS is the absorbance of the appropriate
Standard solution; and
LC is the Capsule label claim, in mg. The Capsule shell correction,
ACS, is calculated using the following formula:
in which
ACSS is the absorbance of the
Capsule shell preparation; and
N is the number of Capsule shells used to prepare the
Capsule shell preparation.
Tolerances
Not less than 85% (Q) of the labeled amount of acitretin (C21H26O3) is dissolved in 30 minutes.
Limit of degradation products
Diluent, Mobile phase, System suitability solution, and Chromatographic system
Proceed as directed in the Assay.
Test solution
Use the Assay preparation.
Procedure
Inject a volume (about 25 µL) of the
Test solution into the chromatograph, record the chromatogram, and measure the peak responses. Calculate the percentage of each degradation product in the portion of Capsules taken by the formula:
100(ri / rs)
in which
ri is the peak response for each individual impurity; and
rs is the sum of the responses of all of the peaks: not more than 0.5% of acitretin related compound A, not more than 0.4% of any individual unspecified impurity, and not more than 0.8% of total unspecified impurities is found.
Assay
Diluent
Prepare a suitable mixture of methanol and tetrahydrofuran (13:10).
Mobile phase
Prepare a filtered and degassed mixture of methanol, water, alcohol, and glacial acetic acid (74:21:5:0.5). Make adjustments if necessary (see
System Suitability under
Chromatography
621
).
Standard preparation
In a 100-mL volumetric flask, dissolve about 10 mg of
USP Acitretin RS, accurately weighed, in 80 mL of
Diluent, and sonicate for 5 minutes. Add 8 mL of water, and quantitatively dilute with
Diluent to obtain a solution having a concentration of about 0.1 mg per mL.
System suitability solution
Transfer 2 mL of the Standard preparation to a clear 4-mL glass vial. After sealing the vial with a teflon-lined silicone septum and cap, place the vial on its side in a light chamber, expose it to 400 foot-candles of fluorescent light for 5 minutes, and then completely wrap the vial with aluminum foil. [noteExposure to the fluorescent light allows for the formation of two degradation products: acitretin related compound A and the 9-cis isomer [(E,E,Z,E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid].]
Assay preparation
Carefully separate and place both halves of 10 Capsules into a 100-mL volumetric flask. Stopper and shake the flask to remove the fill. Add 8 mL of water while rinsing any fill from the neck of the flask. Place the flask in a water bath set at 45

for 10 minutes, shaking initially and at 5-minute intervals up to 10 minutes. Place the resulting suspension in an ultrasonic bath for 15 minutes. Dilute with
Diluent to volume, and sonicate for 5 additional minutes. Cool to room temperature and, if necessary, dilute with
Diluent to volume. Filter the suspension, and use the clear filtrate.
Chromatographic system
(see
Chromatography
621
)The liquid chromatograph is equipped with a 365-nm detector and a 4.6-mm × 15-cm column that contains 5-µm L1 packing. The flow rate is about 1.0 mL per minute. Chromatograph the
System suitability solution, and record the peak responses as directed for
Procedure: the resolution,
R, between acitretin related compound A (relative retention time of about 0.84) and acitretin is not less than 3.0; the resolution,
R, between the 9-
cis isomer (relative retention time of about 1.09) and acitretin is not less than 1.8. Chromatograph the
Standard preparation, and record the peak responses as directed for
Procedure: the relative standard deviation for replicate injections of acitretin is not more than 2.0%.
Procedure
Separately inject equal volumes (about 25 µL) of the
Standard preparation and the
Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of acitretin (C
21H
26O
3) in the portion of Capsules taken by the formula:
100C(rU / rS)
in which
C is the concentration, in mg per mL, of
USP Acitretin RS in the
Standard preparation; and
rU and
rS are the peak responses obtained from the
Assay preparation and the
Standard preparation, respectively.